ESTUDIO HEARTBEAT. PERFIL DE LDL-C EN PACIENTES CON EVENTO CARDIOVASCULAR: UN ESTUDIO MULTICÉNTRICO RETROSPECTIVO EN ESPAÑA.

Dades bàsiques

Protocol:
DAI-LDL-2020-01
EURDRACT:
NCT:
Centre:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Any inici:
2021
Any de finalització:
2021
ESTUDIO OBSERVACIONAL

Documents

  • No hi ha documents

Participants

Grups d'Investigació

Finançadors - Promotors

DAIICHI SANKYO ESPAÑA

Resultats de l'Assaig Clínic


An atypical complication of a patent foramen ovale closure device in an adult: Late infective endocarditis

Echeverria, PMB; (...); Martinez-Leon, J

Article. 10.1016/j.circv.2020.10.007. 2021

  • Open Access.

CA125: a new biomarker in patients with Fontan circulation (vol 76, pg 112, 2023)

Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda

Correction. 10.1016/j.rec.2023.03.018. 2023


CA125: a new biomarker in patients with Fontan circulation.

Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda

Article. 10.1016/j.rec.2022.05.029. 2022


Cardiac Allograft Rejection Induces Changes in Nucleocytoplasmic Transport: RANGAP1 as a Potential Non-Invasive Biomarker.

Lozano-Edo, Silvia; (...); Martinez-Dolz, Luis

Article. 10.3390/jpm12060913. 2022

  • Open Access.

Changes in echocardiographic parameters over time in paradoxical low-flow low-gradient aortic stenosis.

Galian-Gay, Laura; (...); Evangelista, Artur

Article. 10.1093/ehjci/jead067. 2023

  • Open Access.

Plasma Levels of SERCA2a as a Noninvasive Biomarker of Primary Graft Dysfunction After Heart Transplantation.

Lozano-Edo S; (...); Martínez-Dolz L

Article. 10.1097/TP.0000000000003798. 2021


Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients.

Cano J; (...); Romero L

Article. 10.3389/fphar.2020.580481. 2020

  • Open Access.

Rationale and design of the rigorous atrial analysis in advanced interatrial block (ARABIA) prospective study

Martinez-Selles, M; (...); Perez-David, E

Article. 10.1016/j.jelectrocard.2021.08.007. 2021


Value of SERCA2a as a Biomarker for the Identification of Patients with Heart Failure Requiring Circulatory Support.

Ezzitouny M; (...); Martínez-Dolz L

Article. 10.3390/jpm11111122. 2021

  • Open Access.

Compartir el projecte